Understanding the tumor microenvironment in head and neck squamous cell carcinoma

Understanding the tumor microenvironment in head and neck squamous cell carcinoma

Abstract Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of tumors. While significant progress has been made using multimodal treatment, the 5‐year survival remains at 50%. Developing effective therapies, such as immunotherapy, will likely lead to better treatment of p...

Full description

Bibliographic Details
Main Authors: Habib Sadeghi Rad, Yavar Shiravand, Payar Radfar, Rahul Ladwa, Chris Perry, Xiaoyuan Han, Majid Ebrahimi Warkiani, Mark N Adams, Brett GM Hughes, Ken O'Byrne, Arutha Kulasinghe
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Clinical & Translational Immunology
Subjects:
biomarkers
head and neck squamous cell carcinoma
human papillomavirus
immune checkpoint inhibitors
immunotherapy
tumor microenvironment
Online Access:https://doi.org/10.1002/cti2.1397

Internet

https://doi.org/10.1002/cti2.1397

Similar Items